RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Rett Syndrome: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Consistent unmet needs and fragmented care in rett syndrome: insights from a multi-country European caregiver study
Tom Pulles et al., Orphanet Journal of Rare Diseases (17 October 2026)
https://doi.org/10.1186/s13023-026-04651-5
- 2.
Distinct Patterns of Adaptive Decision-Making in Mouse Models of Neurodevelopmental Disorders
James Hilber et al., bioRxiv (Cold Spring Harbor Laboratory) (16 October 2026)
https://doi.org/10.64898/2026.10.14.759086
- 3.
30 years from MECP2 discovery: Current landscape of future therapeutic promises for MECP2-related disorders.
Van Esch Hilde, Neuroscience and biobehavioral reviews (16 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42887345/
- 4.
Documenting Trofinetide Treatment Phenotypes in Rett Syndrome with a Dual-LLM Consensus Pipeline
Daniel Palacios et al., arXiv (Cornell University) (15 October 2026)
https://doi.org/10.48550/arxiv.2610.22062
- 5.
Alteration of cholinergic pathway in the enteric nervous system of a mouse model of Rett syndrome.
Borloz Emilie et al., Neurobiology of disease (15 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42702285/
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
NCT06840496 · Recruiting · Phase 3 · Biomed Industries, Inc.
Ages 5 to 20
https://clinicaltrials.gov/study/NCT06840496
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Rett Syndrome
Rett syndrome is a rare genetic condition that affects brain development, mainly in girls. After a period of typical early development, children lose purposeful hand skills and speech. Research into gene therapies and other treatments is progressing.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Abstract Background Rett syndrome is a rare neurodevelopmental disorder associated with functional impairments that emerge in early childhood and persist throughout life. Despite improved understanding of its genetic basis and natural history, therapeutic options remain limited, and care frameworks across Europe are highly variable. This study aimed to characterize the lived experiences, unmet needs, and evolving challenges faced by individuals with Rett syndrome and their caregivers across multiple European countries. Results Sixty caregivers across eight countries completed five-day diaries, and thirty participated in in-depth interviews. The sample represented children (36%), adolescents (42%), and adults (22%) with Rett syndrome; 97% were female. Difficulty using hands (reported by 88% of caregivers) and difficulty communicating (78%) were the most frequently observed symptoms. Daily activities were heavily affected, with symptoms impacting 59% of activities for children, 61% for adolescents, and 38% for adults. Some comorbidities increased with age, including scoliosis (45% in children vs. 92% in adults) and pneumonia (54% in adults). Care demands were substantial, with caregivers of adults spending an average of 41 hours per week providing emotional support alone, along with high time requirements for feeding (20 hours), washing and bathing (8 hours), and administering medication (5 hours). Conclusions Caregiver experiences across Europe reveal a consistent pattern of unmet needs, high symptom burden, and fragmented, poorly coordinated care for individuals with Rett syndrome. The changing needs across the lifespan underscore the importance of anticipatory, multidisciplinary care models and improved transition pathways into adulthood. As participants were recruited through patient advocacy groups, the study population may represent a comparatively informed and healthcare-engaged subgroup of caregivers, highlighting that unmet needs and care challenges across the broader RTT caregiver community may be even greater among families with less access to advocacy networks and specialized support resources. These findings highlight the need for system-level changes and the development of comprehensive, standardized care frameworks for Rett syndrome across Europe.
Common Questions
What is Rett Syndrome?
Rett syndrome is a rare genetic condition that affects brain development, mainly in girls. After a period of typical early development, children lose purposeful hand skills and speech. Research into gene therapies and other treatments is progressing.
How many clinical trials are available for Rett Syndrome?
RareWays currently indexes 65 clinical trials for Rett Syndrome, of which 6 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Rett Syndrome come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Rett Syndrome.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.